NOD-like receptors in the eye: uncovering its role in diabetic retinopathy
Diabetic retinopathy (DR) is an ocular complication of diabetes mellitus (DM). International
Diabetic Federations (IDF) estimates up to 629 million people with DM by the year 2045 …
Diabetic Federations (IDF) estimates up to 629 million people with DM by the year 2045 …
Damage-associated molecular patterns (DAMPs) in retinal disorders
Damage-associated molecular patterns (DAMPs) are endogenous danger molecules
released from the extracellular and intracellular space of damaged tissue or dead cells …
released from the extracellular and intracellular space of damaged tissue or dead cells …
SGLT2 inhibitors improve kidney function and morphology by regulating renal metabolic reprogramming in mice with diabetic kidney disease
YP Lu, ZY Zhang, HW Wu, LJ Fang, B Hu… - Journal of Translational …, 2022 - Springer
Diabetic kidney disease (DKD) is the leading cause of end-stage renal disease (ESRD)
worldwide. SGLT2 inhibitors are clinically effective in halting DKD progression. However, the …
worldwide. SGLT2 inhibitors are clinically effective in halting DKD progression. However, the …
An automatic detection system of diabetic retinopathy using a hybrid inductive machine learning algorithm
Recently, the leading cause of preventable blindness is diabetic retinopathy (DR). Although
there are several undiagnosed and non-treated cases of DR, accurate and adequate retinal …
there are several undiagnosed and non-treated cases of DR, accurate and adequate retinal …
Epigenetic regulation of S100A9 and S100A12 expression in monocyte-macrophage system in hyperglycemic conditions
DM Mossel, K Moganti, V Riabov, C Weiss… - Frontiers in …, 2020 - frontiersin.org
The number of diabetic patients in Europe and world-wide is growing. Diabetes confers a 2-
fold higher risk for vascular disease. Lack of insulin production (Type 1 diabetes, T1D) or …
fold higher risk for vascular disease. Lack of insulin production (Type 1 diabetes, T1D) or …
SARS-CoV-2 spike protein intensifies cerebrovascular complications in diabetic hACE2 mice through RAAS and TLR signaling activation
FN Burnett, M Coucha, DR Bolduc… - International Journal of …, 2023 - mdpi.com
Diabetics are more vulnerable to SARS-CoV-2 neurological manifestations. The molecular
mechanisms of SARS-CoV-2-induced cerebrovascular dysfunction in diabetes are unclear …
mechanisms of SARS-CoV-2-induced cerebrovascular dysfunction in diabetes are unclear …
Systematic review and bioinformatics analysis of plasma and serum extracellular vesicles proteome in type 2 diabetes
JG Arredondo-Damián, JM Martínez-Soto… - Heliyon, 2024 - cell.com
Abstract Background Type 2 diabetes (T2D) is a complex metabolic ailment marked by a
global high prevalence and significant attention in primary healthcare settings due to its …
global high prevalence and significant attention in primary healthcare settings due to its …
Proteomic analysis of plasma sEVs reveals that TNFAIP8 is a new biomarker of cell proliferation in diabetic retinopathy
J Xiao, H Zhang, F Yang, M Xiao, L Zhou… - Journal of Proteome …, 2021 - ACS Publications
Small extracellular vesicles (sEVs) derived from the plasma have been increasingly
recognized as important vehicles of intercellular communication and potential sources of …
recognized as important vehicles of intercellular communication and potential sources of …
Transcriptional comparison of human and murine retinal neovascularization
L Pauleikhoff, S Boneva, M Boeck… - … & visual science, 2023 - iovs.arvojournals.org
Purpose: Retinal neovascularization (RNV) is the leading cause of vision loss in diseases
like proliferative diabetic retinopathy (PDR). A significant failure rate of current treatments …
like proliferative diabetic retinopathy (PDR). A significant failure rate of current treatments …
[HTML][HTML] Hyper-glycemia and insulinemia induce morphological changes and modulate secretion of S100B, S100A8, amyloid β 1–40 and amyloid β 1–42, in a model …
A Kubis-Kubiak, B Wiatrak, A Piwowar - Biomedicine & Pharmacotherapy, 2022 - Elsevier
Glucose metabolism in neuronal tissue declines during neurodegenerative disorders in a
progressive, region-specific, and disease-specific manner. Studies have shown that …
progressive, region-specific, and disease-specific manner. Studies have shown that …